about
BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesisKrüppel-like factor 15 regulates BMPER in endothelial cellsFoxP1 stimulates angiogenesis by repressing the inhibitory guidance protein semaphorin 5B in endothelial cellsBMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiationClinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosisMitochondrial Mechanisms in Septic CardiomyopathyAnticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decadeClinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerationsActivated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibodySIRT3 in Cardiac Physiology and DiseaseDiabetic Cardiomyopathy: Does the Type of Diabetes Matter?Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusionPharmacotherapy in cardiovascular diseases and vascular interventionsLong-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trialLE-PAS, a novel Arnt-dependent HLH-PAS protein, is expressed in limbic tissues and transactivates the CNS midline enhancer elementPronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbitsLeptin augments cerebral hemodynamic reserve after three-vessel occlusion: distinct effects on cerebrovascular tone and proliferation in a nonlethal model of hypoperfused rat brainDual pathway therapy in acute coronary syndrome.Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions.A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRIEffects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials.New three-dimensional echocardiographic system using digital radiofrequency data--visualization and quantitative analysis of aortic valve dynamics with high resolution: methods, feasibility, and initial clinical experience.Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center RegistryTransmyocardial laser revascularization and left ventricular reduction surgery affect ventricular arrhythmias and heart rate variability.Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries.The Diagnosis, Risk Stratification, and Treatment of Brugada SyndromeArteriogenesis in hypoperfused rat brain.Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents.Hirudin in acute coronary syndromes.[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?].New parenteral anticoagulants: focus on factor Xa and thrombin inhibitors.Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction TreMagnetic resonance tissue phase mapping of myocardial motion: new insight in age and gender.[Constrictive pericarditis: etiology, diagnostic work-up, and therapy].Success of arterial revascularization determined by contrast ultrasound muscle perfusion imaging.
P50
Q24312066-A950157A-710A-4ED8-BED3-F88C53F8B66BQ24317601-6A6A26A7-F594-4DB5-A2DB-EB2C931F111BQ24324456-23D0DCDB-A8EE-4FEC-885E-D8630646F046Q24679290-7979F952-E919-465B-BF2E-B45830958367Q26783034-8847A61A-3BE7-42A9-B7B9-0417F6BE94DAQ26801508-62A6DF36-EE1D-46BE-8B9E-C6E455D70A66Q26824864-0A21F3E7-4266-4FDD-93D4-53E2EBAD084CQ27000967-9DD572C3-B4B0-4560-BFE7-E6D5416D1A6CQ27348621-3C0BF860-B458-45B1-AC50-640DB35EB7D9Q28076837-0760B725-6598-42BE-B691-B43CCF412608Q28079593-14F08C76-3E40-4250-B2D7-2F2537AD94DDQ28191966-51D320DF-9DA9-4564-914B-22255AF72ADCQ28211243-7C9CBD3F-152B-432F-836C-0DBAA9F9C575Q28251137-01EE6361-A1BA-456B-BE73-FC578FAA7173Q28508290-DE7507BC-7568-4074-908D-AD08DC2AD665Q28543123-63C6FECE-8017-4F68-B327-56C97484F380Q28572319-B8A2B4DC-6C39-4242-A340-FE0C7AFBEE81Q30252011-80B99C35-4E9B-49FE-A023-F97062B2E333Q30276130-323A2C8A-A8BF-4B85-833C-BCBF8F614728Q30425444-68B7F386-F15F-4C62-BB2E-5B644D44CE72Q30481283-31C9DC50-38DC-43B7-B4CE-EB1E310CB95EQ30785107-5486BBFB-6455-464A-B451-BDF8707EE180Q30799640-FA84AE2C-DD16-4543-9DFF-01A4326A3A47Q31001917-F163383E-472E-498C-AD5A-3DA69E73F25BQ31082869-EEAE0B69-5D95-42E9-AC82-A3D3DB377309Q31124015-5F8624CA-052B-4464-816F-BA11FAFE32FAQ33165991-50198A5B-AB7F-4086-8A6B-C12494CE0735Q33187183-51D9C333-A60F-416A-AA05-64A05DBD9D08Q33198730-2C79F6F1-56AF-42FB-ADCC-EE4B2C03B5A9Q33200701-57BE6A3B-8464-4492-A3ED-0E2172AEC512Q33221332-FFD4560D-13C4-428E-AC9D-8F1A2185ED33Q33246904-ABBD8A39-EA47-4ADC-B0C1-A7E7DA94A04FQ33266325-3EA34AF3-23C7-4370-9DFF-50EC4ED5B3D4Q33345166-395D916E-F448-455D-8A28-EC6AC3DCD539Q33366360-DC1D72B2-146C-42C2-A553-26E909C3C909Q33396701-ADF62895-DAD6-4628-B3E0-3B73721CF9C0Q33467667-78AAD478-77A8-48BF-BDC4-E9DD1F9E911AQ33517585-EC43FEF7-9F57-4D01-B38B-0A1A1D5351D8Q33550889-8A7B2BAC-ABB9-4A01-B769-2040E3C1A6FCQ33693433-EF59485E-1E4D-45D6-BF96-869CB4D2DE3A
P50
description
Duits arts
@nl
deutscher Arzt und Professor an der Universität Freiburg
@de
name
Christoph Bode
@ast
Christoph Bode
@ca
Christoph Bode
@de
Christoph Bode
@en
Christoph Bode
@es
Christoph Bode
@fr
Christoph Bode
@nl
Christoph Bode
@sl
type
label
Christoph Bode
@ast
Christoph Bode
@ca
Christoph Bode
@de
Christoph Bode
@en
Christoph Bode
@es
Christoph Bode
@fr
Christoph Bode
@nl
Christoph Bode
@sl
prefLabel
Christoph Bode
@ast
Christoph Bode
@ca
Christoph Bode
@de
Christoph Bode
@en
Christoph Bode
@es
Christoph Bode
@fr
Christoph Bode
@nl
Christoph Bode
@sl
P101
P108
P214
P227
P244
P106
P108
P1559
Christoph Bode
@de
P19
P21
P214
P227
P244
n2007184997
P31
P734
P735
P7859
lccn-n2007184997